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Abstract
Background: Wheezes and crackles are well-known signs of lung diseases, but can also be heard in apparently
healthy adults. However, their prevalence in a general population has been sparsely described. The objective of this
study was to determine the prevalence of wheezes and crackles in a large general adult population and explore
associations with self-reported disease, smoking status and lung function.
Methods: We recorded lung sounds in 4033 individuals 40 years or older and collected information on self-reported
disease. Pulse oximetry and spirometry were carried out. We estimated age-standardized prevalence of wheezes and
crackles and associations between wheezes and crackles and variables of interest were analyzed with univariable and
multivariable logistic regressions.
Results: Twenty-eight percent of individuals had wheezes or crackles. The age-standardized prevalence of
wheezes was 18.6% in women and 15.3% in men, and of crackles, 10.8 and 9.4%, respectively. Wheezes were
mostly found during expiration and crackles during inspiration. Significant predictors of expiratory wheezes in
multivariable analyses were age (10 years increase - OR 1.18, 95%CI 1.09–1.30), female gender (1.45, 1.2–1.8),
self-reported asthma (1.36, 1.00–1.83), and current smoking (1.70, 1.28–2.23). The most important predictors of
inspiratory crackles were age (1.76, 1.57–1.99), current smoking, (1.94, 1.40–2.69), mMRC ≥2 (1.79, 1.18–2.65),
SpO2 (0.88, 0.81–0.96), and FEV1 Z-score (0.86, 0.77–0.95).
Conclusions: Nearly over a quarter of adults present adventitious lung sounds on auscultation. Age was the
most important predictor of adventitious sounds, particularly crackles. The adventitious sounds were also
associated with self-reported disease, current smoking and measures of lung function. The presence of
findings in two or more auscultation sites was associated with a higher risk of decreased lung function than
solitary findings.
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Background
Two hundred years after its invention, the relevance of
the stethoscope in modern medical practice has become
a topic of debate [1, 2]. There are some obvious advan-
tages of lung auscultation, such as availability, low cost
and non-invasiveness. Lung auscultation remains thus
an important part of the respiratory examination, mainly
in primary care and in resource-constrained settings.
Lung auscultation has shown to be useful in diagnosing
various respiratory disorders. Adventitious lung sounds
(ALS) such as wheezes and crackles are associated with
common diseases like asthma [3], chronic obstructive pul-
monary disease (COPD) [4, 5], interstitial lung disease [6],
bronchiectasis [7], heart failure [8] and pneumonia [9–11].
Positive findings during auscultation influence clinical de-
cisions such as the rate of antibiotic prescriptions [12, 13]
and referrals to specialist care [14].
Presence of ALS alone, however, only show moderate
sensitivities and specificities, limiting their diagnostic
utility [15–17]. This modest accuracy is mainly related
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to the fact that both wheezes and crackles can also be
present in apparently healthy adults [10, 18–20]. To de-
termine the real usefulness of ALS it is crucial to define
first their behavior, presence and characteristics, in ap-
parently healthy people. Most studies to date, however,
have investigated how ALS relate to specific diagnostic
categories without considering their distribution across
the whole spectrum from health to disease. Moreover,
the few existent studies investigating ALS in apparently
healthy people used small samples [19], failing to be rep-
resentative of the general population. The prevalence of
wheezes and crackles in a general population has never
been reported. [21].
With this study, we aimed to estimate the prevalence
of wheezes and crackles in a large general adult popula-
tion. We also explored to which degree ALS are associ-
ated with self-reported disease, smoking status and
clinical measures of lung function.
Methods
Design and participants
The Tromsø Study is an epidemiological survey that
started in 1976 with the main goal to determine the rea-
sons for the high cardiovascular mortality in the munici-
pality of Tromsø, Norway. The study has been
periodically repeated with the last survey (7th) taking
place in 2015–16.Details of the Tromsø Study can be
consulted elsewhere [22, 23].
In this cross-sectional study, our sample consisted of
randomly selected participants attending the second visit
of the seventh survey of the Tromsø study (Tromsø 7),
between May 2015 and October 2016. All Tromsø resi-
dents 40 years and older (n = 32,591) received a postal
invitation to participate in the first visit of Tromsø 7. A
random sample was selected for the second visit includ-
ing 20% of those aged 40–59 years and 60% of those
aged 60–84 years, and those attending the first visit were
invited. In addition, individuals who had participated in
previous surveys of the study were invited to obtain re-
peated measurements. The mean time between the visits
was of 52 days (± 32). All study participants provided
written consent. The Regional Committee for Medical
and Health Research Ethics in North Norway approved
the study.
Questionnaires and examinations
In the first visit, the participants filled a questionnaire
that included questions on medical conditions such as
arterial hypertension, heart failure, atrial fibrillation,
COPD, asthma, among others. For each condition, the
participants were asked to specify if it was a current
diagnosis, if they had that diagnosis at some point in the
past or if they never had that diagnosis. They also
responded questions about smoking habits. The full
questionnaires employed at the Tromsø Study can be
consulted in English elsewhere [22].
At the second visit, the participants answered the modi-
fied Medical Research Council questionnaire (mMRC) on
dyspnea [24]. Dyspnea was further characterized using the
question: “How is your breathing today compared to
normal?”. To better characterize the respiratory status,
participants were also asked if they had respiratory infec-
tion in the previous week (“Have you had symptoms of
common cold, bronchitis or other airway infection the last
7 days?”).
Spirometry was performed using SensorMedics Vmax
20c Encore (VIASYS Healthcare Respiratory Technolo-
gies, Yorba Linda, CA, USA). Calibration was done daily.
We followed the standards of the American Thoracic
Society (ATS)/ European Respiratory Society (ERS) [25].
Tests with FEV1 < 0.3 l and with expiration lasting for
less than 3 s were regarded invalid. We did not perform
post-bronchodilator measurements. We used the Global
Lung Function Initiative (GLI 2012) as a reference [26].
We registered arterial oxygen saturation (Sp02) with a
pulse oximeter Onyx II model 9550 (Nonin Medical,
Inc., Plymouth, MN, USA) after resting 15min. The
highest value after three measurements was registered.
We accepted only SpO2 ≥ 80% due to uncertain validity
of lower values (n = 1). At the end of this second visit we
recorded lung sounds.
Recording of the lung sounds
We used a microphone MKE 2-EW with a wireless system
EW 112-P G3-G (Sennheiser electronic GmbH, Wede-
mark, Germany), placed in the tube of a Littmann Classic
II stethoscope (3M, Maplewood MN, USA) at 10 cm from
the headpiece. The signal went to an external sound card
(Scarlett 2i2, Focusrite Audio Engineering Ltd., High
Wycombe UK) which connected to a computer’s audio
input. The computer used custom developed software to
label the sounds (participant ID, recording site) and
allowed us to start the recording with a wireless control
(R700, Logitech Europe S.A., Lausanne Switzerland).
We recorded in a quiet room with the participants sit-
ting and the thorax exposed. They were asked to breathe
deeper than normal with an open mouth. We started the
recordings on inspiration and recorded for 15 s. We per-
formed the same procedure subsequently at six different
locations (Fig. 1). The quality of the recordings was
monitored using a wireless headset (SDR 160, Sennhei-
ser electronic GmbH, Wedemark, Germany). If the
health professional deemed the quality to be unsatisfac-
tory, a second attempt was performed.
We obtained audio files in “.wav” format at a sample
rate of 44,100 Hz and 16-bit depth in a single (mono-
phonic) channel. We did not implement audio filters or
other digital pre or post-processing techniques.
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Classification of the recordings
The classification process consisted of three steps.
At the first step, two observers independently listened to
all the recordings with a headset and simultaneously
viewed the sound spectrograms using Adobe Audition 5.0
(Adobe Systems, San Jose, CA, USA). J.C.A. was observer
1 and either R.E., A.D. or C.J. were observer 2. They evalu-
ated if the recording contained wheezes (including rhon-
chi), crackles or other ALS and whether these were heard
in inspiration or expiration. They entered their findings in
an electronic form (Access, Microsoft Corporation, Red-
mond WA, USA) and registered if artefactual noise made
the classification difficult. The observers could listen to
the recordings with freedom to stop or repeat parts or the
whole recording if necessary. They were blinded to any in-
formation about the participant. Agreement and kappa
statistics were calculated accounting for the clustered
structure of the data using the R package “magree”. [27].
At the second step, all disagreements were evaluated
with the two initial observers and a third experienced
observer (H.M.). The three observers listened to the
sounds and solved disagreements through consensus. If
consensus was difficult to reach at this point, the sounds
were submitted for classification at the third step.
At the third step, all recordings classified as containing
ALS were re-classified by two pairs of observers consisting of
one junior (J.C.A. and C.J.) and senior (H.P. and H.M.) lung
sound researcher each. These observers had the possibility to
mark the findings as “certain”, “possible” or “absent”. A find-
ing was changed into absent when wheezes or crackles were
marked as “absent” or “possible” by both observers. Findings
classified as “present” by one observer and “absent” by the
other were discussed in a face-to-face meeting with all the
four observers. Agreement between at least three out of four
observers was required to classify an ALS as “present”. At
the same session, difficult sounds from step two and sounds
categorized as “other sounds” were classified.
All observers performed an audiometry at the time of
involvement in the project. All observers had normal
hearing.
Statistical methods
We calculated age-standardized prevalence of wheezes
and crackles in men and women using the population
distribution from the municipality of Tromsø per
January 2018 [28]. The ALS were divided into three
categories: wheezes and no crackles, crackles and no
wheezes, and both wheezes and crackles, irrespective
of respiratory phase. We calculated prevalence by par-
ticipant characteristics and used linear models to
explore statistically significant differences among the
groups. Tukey’s procedure was used to account for
multiple testing. The continuous variables were di-
chotomized with cutoff values for age ≥ 65 years, for
oxygen saturation ≤ 95% [29], mMRC score ≥ 2 [30],
Body Mass Index (BMI) ≥30 (obesity threshold) and
FEV1 below the lower limit of normal (LLN), accord-
ing to the Global Lung Initiative reference [26].
We used univariable logistic regression to study
wheezes and crackles in relation to the variables of inter-
est. In this analysis, wheezes were counted as present
also when accompanied by crackles and vice versa. The
following outcome variables were considered separately:
(1) any wheeze, (2) wheezes only during the inspiratory
phase, (3) wheezes during the expiratory phase and (4)
wheezes during the expiratory phase at two or more re-
cording sites. For crackles, the outcomes were (1) any
crackle, (2) inspiratory crackles, (3) inspiratory crackles
at two or more locations, (4) only expiratory crackles.
The categorical variables of FEV1 < LLN and SpO2 ≤ 95%
were substituted by continuous data (FEV1 Z-score and
SpO2%) to avoid loss of information. We divided age per
decades and kept it as a continuous variable. The vari-
ables of self-reported disease were dichotomized as
Fig. 1 Recording sites and prevalence of findings. (1 and 2) Between the spine and the medial border of the scapula at the level of T4–T5; (3 and
4) at the middle point between the spine and the mid-axillary line at the level of T9–T10; (5 and 6) at the intersection of the mid-clavicular line
and second intercostal space. Cr = crackles, Wh = wheezes, Insp = inspiratory, Exp = expiratory
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present (which included both present or past diagnosis)
and absent (never diagnosed).
All statistically significant variables for each outcome
in the univariable analyses were entered into multivari-
able logistic regression models. We performed a back-
ward elimination procedure with a threshold of p < .05
to obtain the best fitting models for each outcome. We
plotted Receiver Operator Characteristics (ROC) curves
for all the final models and calculated the area under the
curve (AUC) with the r package “pROC” [31]. Multicolli-
nearity in the final models was assessed using variance
inflation factor with the statistical package “car” [32].
We used R statistical computing version 3.2.1 package to
perform all the calculations [33]. Results were consid-
ered significant at 5% level.
Results
Participants
Tromsø 7 had an attendance of 21,083 (65%) in the first
visit [22]. Of these, 9253 had been selected in advance to
be invited to the second visit, and 90% (n = 8346) took
part. Limited by absences of the staff, we recorded lung
sounds in 6035 (72.3%). Restricted by human resources
and time constraints, only 4033 participants were in-
cluded in the classification procedure. Our final number
of participants represents 19.1% of the participation in
Tromsø 7 and 48.3% of those attending the second visit.
A comparison of the main characteristics between all
the participants of Tromsø 7 and the final study sample
and the flow diagram of the participants included in our
analyses are available online. (Additional file 1: Table S1,
Additional file 2: Figure S1).
General characteristics of the groups
The mean age of all 4033 participants was 63.5 years,
and 2159 (53.5%) were female. (Table 1). There were
477 (11.0%) and 2372 (47%) current and previous
smokers, respectively. We found an FEV1 < LLN in 286
(7.1%) participants and 182 (4.5%) had oxygen satur-
ation ≤ 95% (Table 1). We observed that women had
lower proportion of myocardial infarction, heart failure
and past smokers, but they presented a higher propor-
tion of self-reported asthma, dyspnea (mMRC) and oxy-
gen saturation ≤ 95%.
Classification agreement
We included 24,198 (4033 × 6 recording sites) recordings
for classification. At the first step the observers agreed
on inspiratory wheezes in 98.7% of the recordings (kappa
(k) = 0.43; 95%CI 0.37–0.49), on expiratory wheezes
96.2% (k = 0.56; 0.53–0.59), on inspiratory crackles in
96.5% (k = 0.46; 0.42–0.49), and on expiratory crackles in
98.5% (k = 0.20; 0.15–0.25). Examples of the recordings
can be consulted online (Additional file 3: Figure S3).
At the second step, 1257 recordings were marked as
containing wheezes and 894 containing crackles. At the
third step we discarded wheezes in 224 of these record-
ings and crackles in 174.
The presented prevalence of ALS are based on six re-
cordings in 3771 (93.5%) participants. However, in 262
(6.5%) of the participants included in the analysis there
was noise in one or more recordings. Five recording sites
were considered in 223 (5.5%) participants and four or
less recording sites in 39 (1%) participants.
Prevalence of wheezes and crackles
We found 28% (n = 1131) of individuals with ALS at
least at one recording site. Of these, 599 (14.9%) had
only wheezes, 402 (10.0%) had only crackles and 130
(3.2%) had both wheezes and crackles (Table 2). Expira-
tory wheezes and inspiratory crackles were the most
common findings (Fig. 1). Of the 729 participants with
wheezes, 534 (73.3%) had wheezes at one location, 132
(18.1%) at two locations, 63 (8.6%) at three or more loca-
tions. Of the 532 participants with crackles, 381 (71.6%)
had crackles at one recording site, 127 (23.9%) at two re-
cording sites, 24 (4.5%) at three or more recording sites.
Inspiratory crackles were more frequent at the bases
(Fig. 1).
The age-standardized prevalence of wheezes was
18.6% for women and 15.3% for men and of crackles,
10.8 and 9.4%, respectively. The prevalence of ALS in-
creased significantly with age in both men and women
(p < .001). This was particularly the case for crackles
(Fig. 2). Pleural rub and bronchial breathing were rarely
noticed, each in only two participants.
Wheezes or crackles were found in more than 40% of
participants with the following characteristics: self-re-
ported COPD, mMRC≥2, FEV1 < LLN and SpO2 ≤ 95%
(Table 2). These characteristics were also associated with
the highest prevalence of having both wheezes and
crackles, 6.6–8.8% (Table 2).
Predictors of wheezes
In the univariable analysis, we found that wheezes were
associated with age (10 years increase), female gender,
self-reported asthma, current smoking, mMRC≥2, and a
reduction in FEV1 Z-score, (Table 3). The associations
with mMRC≥2, current smoking and FEV1 Z-score were
stronger for inspiratory than for expiratory wheezes. In
the multivariable analysis age, female gender, self-re-
ported asthma, and current smoking predicted the oc-
currence of expiratory wheezes (Table 4). FEV1-Z score
was a significant predictor for the occurrence of inspira-
tory wheezes. The AUC for all the multivariable models
were similar (0.59–0.60, Table 4). Multicollinearity was
not problematic since the maximum variance inflation
factor was < 1.07.
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Predictors of crackles
The explanatory variables were stronger predictors of
crackles than of wheezes (Table 3). Age and gender were
the only variables associated with expiratory crackles. For
inspiratory crackles, the effect of age, self-reported COPD,
asthma, current and previous smoking, mMRC ≥2, oxygen
saturation and FEV1 Z-score was stronger when inspira-
tory crackles were found at two or more recording sites
than for inspiratory crackles at one site only. Similarly, in
the multivariable analysis the strongest associations were
found in the model with inspiratory crackles heard at two
or more sites as outcome. This was the model with the
highest area under the curve (AUC= 0.79). Inspiratory
crackles appeared more often and at more locations in in-
dividuals with a negative FEV1 Z-score and low oxygen
saturation (Fig. 3). Multicollinearity was not problematic
since the maximum variance inflation factor was < 1.01.
Predictors of wheezes and crackles in the same subject
In the multivariable analysis with both wheezes and
crackles as outcome, age, female gender and FEV1 Z-
score were the significant predictors (data not shown).
The AUC of the model was 0.7.
The variables “respiratory infection previous week”
and “more short of breath than usual” predicted neither
wheezes nor crackles.










Age 63.7 (±10.5) 63.4 (±10.7)
< 65 years 908 (48.5%) 1071 (49.6%)
≥ 65 years 966 (51.5%) 1088 (50.4%)
Body-mass index 12 (0.3%)
< 30 1425 (76.0%) 1683 (78.0%)
≥ 30 445 (23.7%) 468 (21.7%)
Smoking status 59 (1.5%)
Never smoker 686 (36.6%) 916 (42.4%)***
Current smoker 208 (11.1%) 269 (12.5%)
Previous smoker 954 (50.9%) 941 (43.6%)***
Self-reported disease
Hypertension 473 (25.2%) 557 (25.8%) 119 (3.0%)
Myocardial Infarction 141 (7.5%) 57 (2.6%)*** 171 (4.2%)
Heart failure 33 (1.8%) 16 (0.7%)** 175 (4.3%)
Atrial Fibrillation 92 (4.9%) 80 (3.7%) 178 (4.4%)
COPD 74 (3.9%) 87 (4.0%) 157 (3.9%)
Asthma 128 (6.8%) 196 (9.1%)** 254 (6.3%)
Rheumatoid arthritis 83 (4.4%) 117 (5.4%) 227 (5.6%)
Airways infection last week § 278 (14.8%) 303 (14.0%) 165 (4.1%)
Dyspnea
mMRC 165 (4.1%)
mMRC 0 1323 (70.6%) 1368 (63.4%)***
mMRC 1 412 (22.0%) 575 (26.6%)***
mMRC 2–4 70 (3.7%) 120 (5.6%)**
Breathing worse than usual § 210 (11.2%) 242 (11.2%) 156 (3.9%)
Oxygen saturation, SpO2 161 (4.0%)
≤ 95% 110 (5.9%) 72 (3.3%)***
Spirometry
FEV1 < LLN † 150 (8.0%) 136 (6.3%) 234 (5.8%)
Abbreviations: mMRC =Modified Medical Research Council questionnaire, FEV1 = Forced Expiratory Volume in one second, LLN = Lower Limit of Normal
§On examination day
***p value <.001, **p value <.01, *p value <.05 as compared to male by X2 test
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Discussion
Wheezes and crackles were common findings. Any of
these sounds were found in almost one third of our sam-
ple. Wheezes and crackles were associated with increas-
ing age. The sounds were not always related to clinically
diagnosed disease, but their prevalence increased in the
presence of decreased lung function or chronic shortness
of breath.
We are not aware of any comparable study carried out
in a general population. An investigation with 700
Table 2 Frequency of wheezes, crackles and both by characteristics of the study population
Normal Wheezes, no crackles Crackles, no wheezes Both crackles and wheezes
n (%) n (%) n (%) n (%)
All (n = 4033) 2902 (72.0%) 599 (14.9%) 402 (10.0%) 130 (3.2%)
Age
< 65 years 1539 (77.8%) 277 (14.0%)** 123 (6.2%)*** 40 (2.0%)***
≥ 65 years 1363 (66.4%) 322 (15.7%) 279 (13.6%) 90 (4.4%)
Gender
Male 1389 (74.1%) 190 (13.4%) 251 (10.1%) 44 (2.3%)
Female 1513 (70.1%) 348 (16.1%) * 212 (9.8%) 86 (4.0%)**
Body-mass index
< 30 2232 (71.8%) 483 (15.5%)* 292 (9.4%) 101 (3.2%)
≥ 30 663 (72.6%) 114 (12.5%) 107 (11.7%) 29 (3.2%)
Smoking status
Never smoker 1209 (75.5%) 227 (14.2%) 133 (8.3%)** 33 (2.1%)**
Current smoker 299 (62.7%) 89 (18.7%) ** 64 (13.4%) ** 25 (5.2%) **
Previous smoker 1349 (71.2%) 278 (14.7%) 198 (10.4%) 70 (3.7%)
Self-reported disease
Healthy † 1177 (76.8%) 218 (14.0%) 120 (7.0%)*** 38 (2.4%)*
Hypertension 722 (70.1%) 151 (14.7%) 120 (11.7%) 37 (3.6%)
Myocardial Infarction 123 (62.1%) 35 (17.7%) 30 (15.2%) * 10 (5.1%)
Heart failure 32 (65.3%) 11 (22.4%) 5 (10.2%) 1 (2.0%)
Atrial Fibrillation 114 (66.3%) 29 (16.9%) 25 (14.5%) 4 (2.3%)
COPD 95 (59.0%) 27 (16.8%) 30 (18.6%) *** 9 (5.6%)
Asthma 209 (64.5%) 55 (17.0%) 38 (11.7%) 22 (6.8%) **
Rheumatoid arthritis 129 (64.5%) 29 (14.5%) 30 (15.0%) * 12 (6.0%)
Airways infection last week § 427 (73.5%) 89 (15.3%) 44 (7.6%)* 21 (3.6%)
Dyspnea
mMRC
mMRC 0 1996 (74.2%) 388 (14.4%) 239 (8.9%)** 68 (3.7%)**
mMRC 1 688 (69.7%) 148 (15.0%) 111 (11.2%) 40 (4.1%)
mMRC 2–4 109 (57.4%) 30 (15.8%) 36 (18.9%) *** 15 (7.9%) ***
Breathing worse than usual § 321 (71.0%) 70 (15.5%) 47 (10.4%) 14 (3.1%)
Oxygen saturation SpO2
≤ 95% 106 (58.2%) 25 (13.7%) 35 (19.1%)*** 16 (8.8%)***
Spirometry
FEV1 < LLN ‡ 175 (61.2%) 52 (18.2%) 40 (14.0%)* 19 (6.6%)***
Abbreviations: mMRC =Modified Medical Research Council questionnaire, FEV1 = Forced Expiratory Volume in one second, LLN = Lower limit of Normal
Plus-minus values are means + − SD
Percentages (%) represent the distribution of each variable between the different groups
***p value <.001, **p value <.01, *p value <.05 as compared to normal
† Not current smokers who stated not to have any of the diseases considered for this analysis
‡ Calculated from Global Lung Function Initiative reference (GLI)
§ On examination day
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participants conducted by Murphy et al., found wheezes
and rhonchi in 4 and 4%, respectively, in a subgroup of
334 apparently healthy adults. Wheezes were heard in
59% of patients with asthma. For crackles, the prevalence
was 21% in the apparently healthy group and 71% in pa-
tients with COPD. [10] These prevalences were higher
than what we observed, except for wheezes in the appar-
ently healthy group. In their study, the age of the partici-
pants was not taken into account. They included more
recording sites than in ours and used a computerized
classification of the sounds. Different sensitivities of the
classification methods may partly explain the discord-
ance in prevalence. Crackles detected by a computer al-
gorithm may be inaudible with a stethoscope since
crackles may be masked by normal sounds. [34].
In most participants with ALS in our study, these were
heard at only one of the six recording sites. The number
of sites with positive findings had an impact on the asso-
ciations. The model with inspiratory crackles at two or
more locations as outcome performed better than the
model predicting any crackles, reaching an AUC of 0.79.
No similar effect of increasing number of sites was
found regarding wheezes.
The importance of age was described by Kataoka et
al., who observed a rising prevalence of crackles from
11% in cardiovascular asymptomatic adults 40–65
years to 70% in participants 80–95 years old. [35]
Murphy et al. found an association with age among
asbestos exposed workers. [36] Age relates to a reduc-
tion of supporting tissue around the airways causing
a premature closure of the airways. [37]. The influ-
ence of lung and heart disease associated with ageing
might have contributed to the strong association
between crackles and age in our study, an influence
beyond what indicated by self-reported diseases, spir-
ometry and pulse oximetry.
Self-reported asthma was associated with wheezes,
which was in line with previous studies. [3] Hyperten-
sion, self-reported asthma, myocardial infarction, self-re-
ported COPD, and RA were associated with crackles in
the univariable analysis, but only the latter two remained
statistically significant in the multivariable models. The
association of crackles with RA could be explained by
the presence of parenchymal lung abnormalities in pa-
tients with this diagnosis. [38] However, we did not have
an independent confirmation of the diagnosis. Self-re-
ported heart failure was not associated with crackles
probably due to underdiagnosed heart failure [39]. Inter-
estingly, symptoms suggestive of airway infection the
week before the examination was not an independent
predictor of crackles or wheezes. In a European study
from primary care of 2810 adults with acute cough,
crackles were registered in 31% of patients in the pneu-
monia group. [40] Since the prevalence of pneumonia in
this study was only 5%, and probably far less in our
study, it is likely that crackles represented chronic rather
than acute changes in the lungs in most cases.
Women had a higher prevalence of wheezes than men.
Considering subcategories of wheezes, this observation
was valid for expiratory but not for inspiratory wheezes.
The same gender disparity has been reported in epi-
demiological studies on self-reported wheeze [41, 42].
Although wheezing is more common in male newborns
and infants, this gender difference seems to change
sometime during adolescence when females start to
show a higher risk of wheezing. [43] Our findings indi-
cate that this may persist into later adulthood.
Oxygen saturation was significantly associated with the
presence of inspiratory crackles. Crackles are related to
the sudden opening of closed airways or to air move-
ment through obstructed airways. [44] These conditions
may impair ventilation/perfusion matching, the most
Fig. 2 Prevalence of wheezes and crackles by age (in years). Dotted lines represent standardized prevalence rates
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common cause of hypoxemia, which could explain the
relationship in our study. [37].
Strengths and limitations
To our knowledge, this is the largest sample characteriz-
ing the occurrence of wheezes and crackles to date.
Tromsø 7 had a high response rate (65%). The study has
a high external validity for the Norwegian population.
[23] Nevertheless, our results might not be valid in other
populations, for instance in those with poorer health.
Unhealthy people may be underrepresented since some
might have chosen to refrain from participation or were
not able to attend and complete the survey.
The questionnaires employed at Tromsø 7 did not ask
about the presence of interstitial lung disease and bron-
chiectasis. Both conditions have an increased prevalence
with age [45, 46] and are associated with the presence of
crackles [6, 7]. It is possible that participants with these
conditions were categorized as apparently healthy and
this constitutes a limitation of our study.
All the selection processes were randomized and took
place prior to the classification of the recordings without













Age (×0.1) – 1.2*** (1.1–1.3) 1.2** (1.1–1.5) 1.8*** (1.6–2.0) 1.5** (1.2–1.9) 2.2*** (1.8–2.9)
Female Gender – 1.5*** (1.2–1.8) 1.5* (1.1–2.1) – – –
COPD – – – – – 2.3** (1.3–4.1)
Asthma – 1.4* (1.0–1.8) 1.9** (1.1–3.0) – – –
Rheumatoid
Arthritis
– – – 1.6* (1.1–2.3) – –
Current smoker – 1.7*** (1.3–2.2) – 1.9*** (1.4–2.7) – –
Previous smoker – 1.1 (0.9–1.3) – 1.3* (1.0–1.6) – –
mMRC≥ 2 – – – 1.8** (1.2–2.6) – –
Oxygen saturation
SpO2 (1%)
– – – 0.9** (0.8–1.0) – 0.7*** (0.6–0.8)
FEV1 Z-score (1
unit)
0.7*** (0.6–0.8) – – 0.9** (0.8–1.0) – 0.7*** (0.6–0.8)
AUC .59 (0.54–0.64) .59 (0.56–0.62) .60 (0.55–0.64) .69 (0.67–0.72) .62 (0.56–0.69) .79 (0.75–0.84)
Confidence intervals shown in brackets. 2+ = presence of the adventitious sounds in more than two locations. mMRC =Modified Medical Research council
questionnaire. FEV1 = Forced expiratory volume in 1 s, AUC = Area under the curve
***p value < .001, **p value < .01, *p value <.05
Fig. 3 Occurrence of Inspiratory crackles by Z-score FEV1 (reference GLI 2012) and SpO2. LLN = Lower Limit of Normal
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having any knowledge of the health status of the partici-
pants. When randomizing for the second visit a higher
representation was chosen among those aged 60 years or
more, and the subjects invited due to participation in
previous surveys of the Tromsø study were usually 60
years or older. In terms of prevalence, we have taken
care of this selection bias by age standardization, but
some influence on associations with self-reported dis-
eases and lung function cannot be excluded.
The inter-observer agreement at the first step of our
classification compares to that found among general
practitioners. [47] The repeated independent classifica-
tions have without doubt increased the reliability. [48] A
lack of reliability could have influenced our results by di-
luting the strength of the estimates. At the third step of
the classification, we chose to discard as positive findings
the recordings marked as “possible” by two observers. In
a sensitivity analysis, they were classified as “present” but
the results were similar, and our conclusions unchanged.
Conclusion
Our findings support a cautious attitude when using ALS
to diagnose lung disease in elderly patients. The presence
of wheezes or crackles in one lung location did not
strongly predicted the outcomes analyzed. Nonetheless, it
is possible that these solitary findings are a manifestation
of lung senescence and/or represent subclinical disease in
apparently healthy subjects. However, when inspiratory
crackles at two or more locations or both wheezes and
crackles are heard, risk of decreased lung function in-
creases considerably. Such findings, particularly when un-
expected in a patient, should lead to further investigation
regarding possible heart or lung disease.
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